Select Medical Holdings Corporation (SEM) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
Revenue Growth Metrics
Revenue Breakdown (FY 2025)
SEM's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
SEM Revenue Analysis (2014–2025)
As of February 28, 2026, Select Medical Holdings Corporation (SEM) generated trailing twelve-month (TTM) revenue of $3.93 billion, reflecting significant decline in growth of -22.6% year-over-year. The most recent quarter (Q3 2025) recorded $1.36 billion in revenue, up 1.8% sequentially.
Looking at the longer-term picture, SEM's 5-year compound annual growth rate (CAGR) stands at -0.3%, indicating revenue contraction over this period. The company achieved its highest annual revenue of $6.66 billion in 2023.
Revenue diversification analysis shows SEM's business is primarily driven by Health Care, Patient Service, Non-Medicare (61%), Health Care, Patient Service, Medicare (29%), and Service, Other (10%). With over half of revenue concentrated in Health Care, Patient Service, Non-Medicare, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including ENSG (+17.5% YoY), EHC (+11.1% YoY), and BKD (+7.3% YoY), SEM has underperformed the peer group in terms of revenue growth. Compare SEM vs ENSG →
Peer Comparison
Compare SEM's revenue metrics with industry peers
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| SEMCurrent | $3.9B | -22.6% | -0.3% | 0.0% | |
| ENSG | $5.1B | +17.5% | +16.1% | 8.4% | |
| EHC | $5.9B | +11.1% | +10.7% | 12.8% | |
| BKD | $3.2B | +7.3% | +1.1% | 2.7% | |
| NHC | $1.5B | +22.1% | +8.4% | 8.7% | |
| PNTG | $948M | +36.3% | +19.4% | 5.5% |
Historical Revenue Data
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $5.45B | +5.1% | $629.3M | 11.5% | $1.6M | 0.0% |
| 2024 | $5.19B | -22.2% | $633.6M | 12.2% | $268.3M | 5.2% |
| 2023 | $6.66B | +5.2% | $932.0M | 14.0% | $554.9M | 8.3% |
| 2022 | $6.33B | +2.1% | $733.4M | 11.6% | $403.3M | 6.4% |
| 2021 | $6.20B | +12.2% | $919.4M | 14.8% | $713.8M | 11.5% |
| 2020 | $5.53B | +1.4% | $821.3M | 14.8% | $567.7M | 10.3% |
| 2019 | $5.45B | +7.3% | $812.9M | 14.9% | $471.9M | 8.7% |
| 2018 | $5.08B | +14.3% | $740.2M | 14.6% | $417.3M | 8.2% |
| 2017 | $4.44B | +3.7% | $709.4M | 16.0% | $355.9M | 8.0% |
| 2016 | $4.29B | +14.5% | $621.2M | 14.5% | $299.8M | 7.0% |
See SEM's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs SEM Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare SEM vs AGIO
See how SEM stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
Is SEM's revenue growth accelerating or slowing?
SEM revenue declined -22.6% year-over-year, contrasting with the 5-year CAGR of -0.3%. TTM revenue fell to $3.9B. This reverses the prior growth trend.
What is SEM's long-term revenue growth rate?
Select Medical Holdings Corporation's 5-year revenue CAGR of -0.3% reflects the variable expansion pattern. Current YoY growth of -22.6% is below this long-term average.
How is SEM's revenue distributed by segment?
SEM reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.